Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive gastric cancer: a dose-expansion, phase 1 study

出版年份 2019 全文链接

标题

作者

关键词

出版物

Volume 20, Issue 6, Pages 827-836

出版商

Elsevier BV

发表日期

2019-04-30

DOI

10.1016/s1470-2045(19)30088-9

联系作者

Discuss science. Find collaborators. Network.

Join a conversation

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now